Bioinformatic and Experimental Analyses Reveal That KIF4A Is a Biomarker of Therapeutic Sensitivity and Predicts Prognosis in Cervical Cancer Patients
ConclusionKIF4A is a tumor suppressor gene in cervical cancer, and it can be used as a prognostic and therapeutic biomarker in cervical cancer.
Source: Journal of Huazhong University of Science and Technology -- Medical Sciences -- - Category: Research Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Chemotherapy | Databases & Libraries | Genetics | Immunotherapy | Research | Science | Study